Developer docs
API playgroundTry for free, no card

Search company profiles

National Foundation for Cancer Research

Full company profile

uuid000hmdz

Namestring
National Foundation for Cancer Research
Legal namestring
National Foundation for Cancer Research
Websiteurl
nfcr.org
Company typeenum
Private
Founded yearint
1973
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRockville, United States
HQ citystring
Rockville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer research funding, nonprofit philanthropy, cancer information resources, charitable donations, research grants
Industry3 codes
1Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryYes
2Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryNo
3Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)
CodeHLAJAOAMPrimaryNo
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
SIC code1 code
  • Services-Engineering, Accounting, Research, Management8700
Product category
Cancer Research Philanthropy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Individual Donations & Tribute Gifts
TypeGrants Donations
Description

NFCR raises funds from individual donors through one-time contributions, monthly sustaining gifts (Champion for a Cure program), tribute gifts in honor or memory of loved ones, and bequests/legacy gifts.

nfcr.org
2Workplace Giving Programs
TypeGrants Donations
Description

NFCR participates in Combined Federal Campaign (CFC Code 11267), Community Health Charities (CHC), United Way, and other workplace giving campaigns allowing employees to donate via payroll deduction.

nfcr.org
3Corporate & Event Sponsorships
TypeGrants Donations
Description

NFCR generates revenue through corporate sponsorships for events such as the Szent-Györgyi Prize ceremony and NFCR Global Summit. Platinum, Gold, and Bronze sponsorship tiers are offered.

nfcr.org
4Retail Partnerships & Affiliate Shopping
TypeAffiliate Referral
Description

NFCR earns revenue through shopping partnerships where retailers (Notch Touchstones, Good Cause Greetings, Teleflora, iGive, Charity Choice, Bonfire) donate a percentage of sales to NFCR.

nfcr.org
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Marketing or Sales, Personnel, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 7 records shown
1Szent-Györgyi Prize
Description

Annual prize for progress in cancer research established in honor of co-founder Albert Szent-Györgyi

nfcr.org
+6 more records
Core offering1 text field

The National Foundation for Cancer Research (NFCR) is a 501(c)(3) public charity that funds high-risk, high-impact cancer research projects and provides cancer information, prevention, and caregiver support resources. It generates revenue through individual donations, workplace giving campaigns, corporate sponsorships, and retail partnership programs, then deploys those funds as research grants to scientists and labs worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over $420 million in research and program support delivered to cancer researchers over 53 years
+2 more records
Product overview1 text field

The National Foundation for Cancer Research (NFCR) operates as a nonprofit research funding organization rather than a technology product company. NFCR's offerings include educational cancer information resources covering 20 cancer types with detection guidelines and prevention materials, the All Things Cancer podcast featuring insights from researchers and survivors, the annual NFCR Global Summit with the Szent-Györgyi Prize ceremony, virtual community platforms like the NFCR Oncology Metaverse, and various fundraising programs including workplace giving, tribute gifts, youth fundraising (Play4TheCure), and signature events like Daffodils & Diamonds. The organization funds research programs including GBM AGILE and AIM-HI Translational Research Initiative to support scientists working on breakthrough cancer treatments and diagnostics.

Product and service1 record
1Champion for a Cure Monthly Giving
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The largest US cancer charity, funding research and patient support across all cancer types. Directly comparable to NFCR as a broad-scope cancer grantmaking and education nonprofit competing for the same individual donor base.

TypeDirect peer
Description

Founded by Jim Valvano, this cancer research grantmaker funds high-impact research across cancer types. Closely comparable to NFCR's high-risk funding thesis and donor demographic of sports-adjacent philanthropic supporters.

TypeDirect peer
Description

Focused on immunotherapy and tumor immunology research funding. Overlaps with NFCR's research funding model and shares the niche of high-risk, scientifically-validated cancer grants.

TypeDirect peer
Description

Funds high-risk, high-reward early-career cancer researchers. Most comparable peer in terms of funding philosophy (innovative research deemed too risky by NIH) and grant size structure.

TypeDirect peer
Description

The dominant breast cancer charity, combining research grants with patient support. Comparable as a disease-area cancer research grantmaker competing in overlapping donor demographic with strong brand affinity.

TypeDirect peer
Description

Disease-specific cancer research funder with broad fundraising programs including workplace giving. Comparable in funding model and donor acquisition through CFC, United Way, and event-based fundraising.

TypeDirect peer
Description

Focuses on cancer prevention research and education. Directly comparable as a smaller-scale cancer research grantmaker sharing NFCR's research-plus-education dual mission and similar funding scale.

TypeEmerging player
Description

Media-driven collaborative cancer research funder using entertainment industry partnerships. Comparable as a research grantmaker, but differentiates via celebrity/entertainment-driven fundraising model that competes for similar donor mindshare.

TypeDirect peer
Description

Founded in 2005 by NFCR CEO Dr. Sujuan Ba as a sister organization focused on cancers prevalent in Asia. Highly comparable as a cancer research grantmaker with shared leadership and mission alignment.

TypeBroad incumbent
Description

Major cancer research institution and hospital. While NFCR is a grantmaker (not a research operator), MSK overlaps in the cancer research ecosystem and competes for philanthropic dollars from cancer-focused donors.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Foundation for Cancer Research

Cancer Research Philanthropynfcr.org

National Foundation for Cancer Research firmographics

Firmographics
Name
National Foundation for Cancer Research
Legal name
National Foundation for Cancer Research
Website
https://nfcr.org
Company type
Private
Founded year
1973
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

National Foundation for Cancer Research industry classification

Industry
Product category
Cancer Research Philanthropy
NAICS
Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
SIC
Services-Engineering, Accounting, Research, Management (8700)
akta.pro primary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)
akta.pro secondary industries
Research & Science Grantmaking Foundations (BPAGAKAI), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

Keywords

  • Cancer research funding
  • Nonprofit philanthropy
  • Cancer information resources
  • Charitable donations
  • Research grants

Where National Foundation for Cancer Research is headquartered

Location

Headquarters

HQ city
Rockville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

National Foundation for Cancer Research business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Marketing or Sales, Personnel, Technology or R&D, Others

Revenue model

  1. Individual Donations & Tribute Gifts: NFCR raises funds from individual donors through one-time contributions, monthly sustaining gifts (Champion for a Cure program), tribute gifts in honor or memory of loved ones, and bequests/legacy gifts.
  2. Workplace Giving Programs: NFCR participates in Combined Federal Campaign (CFC Code 11267), Community Health Charities (CHC), United Way, and other workplace giving campaigns allowing employees to donate via payroll deduction.
  3. Corporate & Event Sponsorships: NFCR generates revenue through corporate sponsorships for events such as the Szent-Györgyi Prize ceremony and NFCR Global Summit. Platinum, Gold, and Bronze sponsorship tiers are offered.
  4. Retail Partnerships & Affiliate Shopping: NFCR earns revenue through shopping partnerships where retailers (Notch Touchstones, Good Cause Greetings, Teleflora, iGive, Charity Choice, Bonfire) donate a percentage of sales to NFCR.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels10 records

National Foundation for Cancer Research product offering

Product offering

Core offering

The National Foundation for Cancer Research (NFCR) is a 501(c)(3) public charity that funds high-risk, high-impact cancer research projects and provides cancer information, prevention, and caregiver support resources. It generates revenue through individual donations, workplace giving campaigns, corporate sponsorships, and retail partnership programs, then deploys those funds as research grants to scientists and labs worldwide.

Product overview

The National Foundation for Cancer Research (NFCR) operates as a nonprofit research funding organization rather than a technology product company. NFCR's offerings include educational cancer information resources covering 20 cancer types with detection guidelines and prevention materials, the All Things Cancer podcast featuring insights from researchers and survivors, the annual NFCR Global Summit with the Szent-Györgyi Prize ceremony, virtual community platforms like the NFCR Oncology Metaverse, and various fundraising programs including workplace giving, tribute gifts, youth fundraising (Play4TheCure), and signature events like Daffodils & Diamonds. The organization funds research programs including GBM AGILE and AIM-HI Translational Research Initiative to support scientists working on breakthrough cancer treatments and diagnostics.

Differentiator

Problem solved

Functional benefit

Brands

  • Szent-Györgyi Prize: Annual prize for progress in cancer research established in honor of co-founder Albert Szent-Györgyi
  • GBM AGILE
  • AIM-HI Accelerator Fund
  • Play4TheCure
  • Daffodils & Diamonds
  • NFCR Global Summit
  • All Things Cancer Podcast

Products and services

  • Champion for a Cure Monthly Giving

Quantifiable outcome

  • Over $420 million in research and program support delivered to cancer researchers over 53 years
  • +2 more outcomes

Companies that use National Foundation for Cancer Research

Customer profile

Segments3 records

Ideal customer profiles5 records

National Foundation for Cancer Research technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

National Foundation for Cancer Research partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

National Foundation for Cancer Research competitors and assessment

Company assessment

Direct peers

  • American Cancer Society: The largest US cancer charity, funding research and patient support across all cancer types. Directly comparable to NFCR as a broad-scope cancer grantmaking and education nonprofit competing for the same individual donor base.
  • V Foundation for Cancer Research: Founded by Jim Valvano, this cancer research grantmaker funds high-impact research across cancer types. Closely comparable to NFCR's high-risk funding thesis and donor demographic of sports-adjacent philanthropic supporters.
  • Cancer Research Institute: Focused on immunotherapy and tumor immunology research funding. Overlaps with NFCR's research funding model and shares the niche of high-risk, scientifically-validated cancer grants.
  • Damon Runyon Cancer Research Foundation: Funds high-risk, high-reward early-career cancer researchers. Most comparable peer in terms of funding philosophy (innovative research deemed too risky by NIH) and grant size structure.
  • Susan G. Komen: The dominant breast cancer charity, combining research grants with patient support. Comparable as a disease-area cancer research grantmaker competing in overlapping donor demographic with strong brand affinity.
  • Leukemia & Lymphoma Society: Disease-specific cancer research funder with broad fundraising programs including workplace giving. Comparable in funding model and donor acquisition through CFC, United Way, and event-based fundraising.
  • Prevent Cancer Foundation: Focuses on cancer prevention research and education. Directly comparable as a smaller-scale cancer research grantmaker sharing NFCR's research-plus-education dual mission and similar funding scale.
  • Asian Fund for Cancer Research: Founded in 2005 by NFCR CEO Dr. Sujuan Ba as a sister organization focused on cancers prevalent in Asia. Highly comparable as a cancer research grantmaker with shared leadership and mission alignment.

Emerging players

  • Stand Up To Cancer: Media-driven collaborative cancer research funder using entertainment industry partnerships. Comparable as a research grantmaker, but differentiates via celebrity/entertainment-driven fundraising model that competes for similar donor mindshare.

Broad incumbents

  • Memorial Sloan Kettering Cancer Center: Major cancer research institution and hospital. While NFCR is a grantmaker (not a research operator), MSK overlaps in the cancer research ecosystem and competes for philanthropic dollars from cancer-focused donors.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

National Foundation for Cancer Research social profiles

Digital presence

National Foundation for Cancer Research financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Foundation for Cancer Research leadership team

Management profile

Number of profiles

Profiles3 records

National Foundation for Cancer Research funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Foundation for Cancer Research M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Foundation for Cancer Research

What does National Foundation for Cancer Research do?

The National Foundation for Cancer Research (NFCR) is a 501(c)(3) public charity that funds high-risk, high-impact cancer research projects and provides cancer information, prevention, and caregiver support resources. It generates revenue through individual donations, workplace giving campaigns, corporate sponsorships, and retail partnership programs, then deploys those funds as research grants to scientists and labs worldwide.

Is National Foundation for Cancer Research a public or private company?

National Foundation for Cancer Research is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was National Foundation for Cancer Research founded?

National Foundation for Cancer Research was founded in 1973. It employs 11 to 50 people.

Where is National Foundation for Cancer Research based?

National Foundation for Cancer Research is headquartered in Rockville, United States, in the North America region.

How does National Foundation for Cancer Research make money?

Four revenue lines are on record. Individual Donations & Tribute Gifts are the primary driver. The others are workplace Giving Programs, corporate & Event Sponsorships and retail Partnerships & Affiliate Shopping.

Who are National Foundation for Cancer Research's main competitors?

Direct peers on record are American Cancer Society, V Foundation for Cancer Research, Cancer Research Institute, Damon Runyon Cancer Research Foundation, Susan G. Komen, Leukemia & Lymphoma Society, Prevent Cancer Foundation and Asian Fund for Cancer Research. Stand Up To Cancer is listed as an emerging player. Memorial Sloan Kettering Cancer Center is listed as a broad incumbent.

Does National Foundation for Cancer Research have an API?

No public API is recorded for National Foundation for Cancer Research.

What industry is National Foundation for Cancer Research in?

National Foundation for Cancer Research's product category is Cancer Research Philanthropy. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGAKAI, Research & Science Grantmaking Foundations. Its NAICS code is 813212 and its SIC code is 8700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBrain Cancer Foundation CEO Announces First-Ever South Pole Trek in the Name of Cancer ResearchLance Kawaguchi, CEO of the Cure Brain Cancer Foundation, announced plans to undertake a trek to the South Pole in December to raise awareness and funds for brain cancer research. The initiative involves partnerships with international charities including the Asian Fund for Cancer Research, the Glioblastoma Research Organization, and the National Foundation for Cancer Research. This effort aims to address the lack of funding for brain cancer treatments, which have remained unchanged for over 30 years.PR NewswireBrain Cancer Foundation CEO Announces First-Ever South Pole Trek in the Name of Cancer ResearchCure Brain Cancer Foundation CEO Lance Kawaguchi has announced he will trek to the South Pole in December to raise awareness and funding for brain cancer research, with the effort targeting glioblastoma, the deadliest form of brain cancer where standard treatments have remained unchanged for over 30 years. Kawaguchi is calling on donors and sponsors globally while partnering with charities across the U.S., Australia, the UK, and Hong Kong, including the Asian Fund for Cancer Research, Glioblastoma Research Organization, and National Foundation for Cancer Research. The foundation has committed $30 million to brain cancer research to date and aims to put the disease on the global agenda through this high-profile expedition.PR NewswireCytocom to Present at the Spring 2021 Virtual Oncology Investor ConferenceCytocom, Inc. announced that its President and CEO Mike Handley will present at the Spring 2021 Virtual Oncology Investor Conference, sponsored by the National Foundation for Cancer Research, scheduled for March 29 to April 1, 2021. During the presentation, Handley will provide an overview of the company's business, recent corporate achievements, and anticipated near-term milestones across clinical programs for COVID-19, pancreatic cancer, and Crohn's disease. The management team will also be available for virtual one-on-one meetings with investors and representatives from biotechnology and pharmaceutical companies registered to attend the conference.PR Newswire2021 Szent-Györgyi Prize Awarded to Pioneering Research Duo Who Have Paved the Path to Life-Saving T-Cell Receptor-Based Cancer ImmunotherapiesThe National Foundation for Cancer Research awarded the 2021 Szent-Györgyi Prize to Dr. Tak W. Mak and Dr. Mark M. Davis for their pioneering research on the T-cell receptor that enabled the development of CAR T-cell therapies. Their discoveries provided the molecular foundation for FDA-approved immunotherapies used to treat blood cancers such as lymphomas and leukemia. The researchers are now collaborating to extend these treatments to solid tumors.PR NewswireDelMar Pharmaceuticals Receives $500,000 Loan from the National Brain Tumor Society and National Foundation for Cancer Research to Support VAL-083's Participation in a Pivotal Study for Glioblastoma SDelMar Pharmaceuticals received a $500,000 loan from the National Brain Tumor Society and National Foundation for Cancer Research to support its drug VAL-083's participation in the Global Coalition for Adaptive Research's GBM AGILE international clinical trial for glioblastoma. The funding is expected to reduce VAL-083's pivotal trial completion and regulatory submission timeline by up to 18 months. Positive results from the VAL-083 arm of GBM AGILE could serve as the basis for FDA approval filing.PR Newswire2020 Szent-Györgyi Prize Awarded to a Pioneering Researcher Who Has Unlocked Workings of Cancer Drugs of Natural Product OriginSusan Band Horwitz, Ph.D., was awarded the 2020 Szent-Györgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research for her groundbreaking work on the mechanisms of action of anti-tumor drugs, particularly Taxol. Her discoveries have enabled the successful clinical translation of this drug, which is widely prescribed for various cancers. The award ceremony will take place on April 25, 2020, in Washington, D.C.PR NewswirePioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer ResearchThe National Foundation for Cancer Research announced that Dr. Steven A. Rosenberg of the U.S. National Cancer Institute has been selected to receive the 2019 Szent-Györgyi Prize for Progress in Cancer Research, recognizing his pioneering contributions to cancer immunotherapy. Dr. Rosenberg's work spanning over four decades has been foundational to the development of therapies including IL-2, adoptive cell transfer, CAR-T therapy, and tumor-infiltrating lymphocyte therapy, contributing to drugs such as Proleukin, Yervoy, and Yescarta. His research established the basis for the first FDA-approved cancer immunotherapy in 1992 for metastatic renal cancer and subsequent approval for metastatic melanoma in 1998.PR NewswireKEW and the National Foundation for Cancer Research Announce Collaboration to Increase Awareness of CANCERPLEX®KEW, Inc. and the National Foundation for Cancer Research (NFCR) announced a collaboration to increase awareness of genetic testing for cancer treatment using KEW's CANCERPLEX suite of products. The partnership aims to educate patients and oncologists about the clinical advantages of next-generation sequencing (NGS) and its role in identifying targeted therapies for patients with specific tumor genetics. This initiative reflects a commitment to advancing personalized medicine for cancer patients.PR NewswireMary-Claire King, Ph.D. of University of Washington Awarded 2016 Szent-Györgyi Prize for Progress in Cancer ResearchThe National Foundation for Cancer Research (NFCR) awarded Mary-Claire King, Ph.D. of the University of Washington the 2016 Szent-Györgyi Prize for Progress in Cancer Research for her discovery of the BRCA1 gene. King's pioneering work provided the first evidence of genetic predisposition to breast cancer and made genetic screening for breast and ovarian cancers possible, fundamentally changing cancer prevention, screening, diagnosis, and treatment approaches. The award ceremony will be held on May 2, 2016, at the National Press Club in Washington, D.C.GlobeNewswirePlay4theCure and the National Foundation for Cancer Research Team Up to Fight CancerPlay4theCure joined the National Foundation for Cancer Research to raise funds for cancer research through sports programs. The partnership enables athletes to support research and provide cancer prevention education. Play4theCure, founded in 2006, has expanded to include middle, high school, and collegiate teams.